HomeBUSINESS
BUSINESS

Pfizer Japan No Longer Disclosing Biosimilar Development Status for “Competitive Reasons”
(Feb.23.2018)

Pfizer Japan has stopped disclosing the development status of its biosimilar pipeline for “competitive reasons,” a company spokesperson told Jiho ...
(LOG IN FOR FULL STORY)

News Calendar